Objectives: The Crohn’s Disease Endoscopic Index of Severity (CDEIS) and the Simple Endoscopic Score for Crohn’s Disease (SES-CD) are commonly used to assess Crohn’s disease (CD) activity; however neither instrument is fully validated. We evaluated the responsiveness to change of the SES-CD and CDEIS using data from a trial of adalimumab, a drug therapy of known efficacy.


Adalimumab, Anti-Inflammatory Agents, Prognosis, Research Design, Crohn's Disease, Drug Therapy, Endoscopy, Gastrointestinal, Diagnosis

Read More